Nanoparticles News and Research RSS Feed - Nanoparticles News and Research

Four iGEM undergraduate competition teams supported by BMG Labtech

Four iGEM undergraduate competition teams supported by BMG Labtech

BMG LABTECH, a leading manufacturer of microplate readers, recently supported four iGEM teams with a microplate reader to fuel their participation at the annual iGEM competition. [More]
Ginger-derived nanoparticles may be good medicine for inflammatory bowel disease

Ginger-derived nanoparticles may be good medicine for inflammatory bowel disease

A recent study by researchers at the Atlanta Veterans Affairs Medical Center took them to a not-so-likely destination: local farmers markets. They went in search of fresh ginger root. [More]
Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry. [More]
Researchers find potential way to reduce effects of TBI with neuron-targeting nanoparticle

Researchers find potential way to reduce effects of TBI with neuron-targeting nanoparticle

A fall down the stairs, a car crash, a sports injury or an explosive blast can all cause traumatic brain injury (TBI). [More]
Researchers develop new nanorobotic agents to deliver drugs by targeting cancerous tumours

Researchers develop new nanorobotic agents to deliver drugs by targeting cancerous tumours

Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research. [More]
Could nanotechnology turn the cancer cell suicide switch back on? An interview with Professor Dipanjan Pan

Could nanotechnology turn the cancer cell suicide switch back on? An interview with Professor Dipanjan Pan

Before I explain the discovery, I would take a step back and explain an interesting event that takes place in the cancer cells. Normal cells follow a rapid and irreversible process to efficiently eradicate dysfunctional cells. This is a natural process by which damaged cells commit ‘suicide’. This process is known as apoptosis or programmed cell death. [More]
Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

Scientists develop novel multifunctional platform to integrate imaging and photo-induced cancer therapy

Physicists from The University of Texas at Arlington are leading a multidisciplinary project with The University of Texas Southwestern Medical Center in Dallas and The University of Texas MD Anderson Cancer Center in Houston to develop a new multifunctional platform that can integrate imaging and photo-induced cancer therapy in a single, portable device. [More]
Russian physicists propose unique method to avoid implants rejection

Russian physicists propose unique method to avoid implants rejection

A group of Russian physicists, with the contribution from their Swiss colleagues, developed a way to use the therapeutic effect of heating or cooling the tissues due to the magnetocaloric effect. [More]
Researchers develop method to kill cancer cells using nanoparticles and lasers

Researchers develop method to kill cancer cells using nanoparticles and lasers

Cancer treatments based on laser irridation of tiny nanoparticles that are injected directly into the cancer tumor are working and can destroy the cancer from within. [More]
Australian researchers use novel Nanolive 3D Cell Explorer for nanotoxicity research

Australian researchers use novel Nanolive 3D Cell Explorer for nanotoxicity research

The Nanolive 3D Cell Explorer is a new and unique instrument using revolutionary technology that affords researchers a view inside living cells like never before. [More]
Preclinical data on Selecta’s novel immune tolerance platform published in Nature Nanotechnology

Preclinical data on Selecta’s novel immune tolerance platform published in Nature Nanotechnology

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta’s research which demonstrate the broad potential applicability of Selecta’s novel immune tolerance platform. [More]
Overcoming gene silencing barriers to target neurological conditions: an interview with Dr Errol de Souza

Overcoming gene silencing barriers to target neurological conditions: an interview with Dr Errol de Souza

Many gene mutations that cause neurological disorders have been identified. For example, in a rare neurological disorder such as Huntington’s disease, an autosomal dominant mutation through expansion of CAG (cytosine-adenine-guanine) triplet repeats in the gene coding for the Huntingtin protein results in abnormal protein production. [More]
UK Export Award winner BBI Solutions to attend 2016 AACC

UK Export Award winner BBI Solutions to attend 2016 AACC

BBI Solutions, recent winners of the Made in the UK Export Award, will be attending the AACC Clinical Lab Expo in Philadelphia next month. [More]
Triple-combination therapy patch shrinks tumors, prevents recurrence in colon cancer mice model

Triple-combination therapy patch shrinks tumors, prevents recurrence in colon cancer mice model

Investigators at Brigham and Women's Hospital have developed a hydrogel patch that can adhere to tumors in a preclinical model of colon cancer, delivering a local, combination treatment as the elastic gel breaks down over time. [More]
Penn researchers use iron-containing nanoparticles to reduce plaque and prevent tooth decay

Penn researchers use iron-containing nanoparticles to reduce plaque and prevent tooth decay

The bacteria that live in dental plaque and contribute to tooth decay often resist traditional antimicrobial treatment, as they can "hide" within a sticky biofilm matrix, a glue-like polymer scaffold. [More]
Adhesive patch can deliver triple combination therapy to tumor sites

Adhesive patch can deliver triple combination therapy to tumor sites

Approximately one in 20 people will develop colorectal cancer in their lifetime, making it the third-most prevalent form of the disease in the U.S. In Europe, it is the second-most common form of cancer. [More]
Salmonella protein can reduce drug resistant molecule found in cancer cells

Salmonella protein can reduce drug resistant molecule found in cancer cells

A surprising result in an experiment on Salmonella bacteria has led to a discovery that may make drug resistant cancer cells more treatable by conventional chemotherapies. [More]
Scientists develop simple method for building complex reconfigurable microrobots

Scientists develop simple method for building complex reconfigurable microrobots

For the past few years, scientists around the world have been studying ways to use miniature robots to better treat a variety of diseases. [More]
Researchers show porous silicon nanoparticles could be harmless to diagnose and treat cancer

Researchers show porous silicon nanoparticles could be harmless to diagnose and treat cancer

The Lomonosov Moscow State University researchers in collaboration with their German colleagues have succeeded in proving that silicon nanoparticles can be applied to diagnose and cure cancer. [More]

New research delves into physical properties of nanoparticles for successful drug delivery

Nanoparticles are being studied as drug delivery systems to treat a wide variety of diseases. New research delves into the physical properties of nanoparticles that are important for successfully delivering therapeutics within the body, with a primary focus on size. [More]
Advertisement
Advertisement